{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T18:11:56Z","timestamp":1758046316191,"version":"3.44.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.pharma.2023.05.005","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T20:37:58Z","timestamp":1685133478000},"page":"856-862","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Potential drug-drug interactions in patients presenting with osteoarthritis to community orthopaedic clinics of Abbottabad, Khyber Pakhtunkhwa: A cross-sectional study"],"prefix":"10.1016","volume":"81","author":[{"given":"Ihtesham ur","family":"Rehman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qasim","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Junaid Hassan","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid","family":"Bashir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Imran","family":"Amirzada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2006","series-title":"Stockley's drug interactions: a source book of interactions, their mechanisms, clinical importance and management","author":"Baxter","key":"10.1016\/j.pharma.2023.05.005_bib0120"},{"year":"2012","series-title":"Clinical pharmacy and therapeutics","author":"Walker","key":"10.1016\/j.pharma.2023.05.005_bib0125"},{"key":"10.1016\/j.pharma.2023.05.005_bib0130","first-page":"1","article-title":"Evaluation of potential drug-drug interactions with medications prescribed to geriatric patients in a tertiary care hospital","author":"Shetty","year":"2018","journal-title":"Age Res"},{"key":"10.1016\/j.pharma.2023.05.005_bib0135","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/pds.3592","article-title":"Hospital admissions\/visits associated with drug-drug interactions: a systematic review and meta-analysis","volume":"23","author":"Dechanont","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"10.1016\/j.pharma.2023.05.005_bib0140","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s40674-016-0042-y","article-title":"Pharmacologic and non-pharmacologic treatment of osteoarthritis","volume":"2","author":"Yusuf","year":"2016","journal-title":"Curr Treat Options Rheumatol"},{"issue":"1","key":"10.1016\/j.pharma.2023.05.005_bib0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.berh.2005.09.007","article-title":"Osteoarthritis: epidemiology","volume":"20","author":"Arden","year":"2006","journal-title":"Best Prac Res Clin Rheum"},{"issue":"1","key":"10.1016\/j.pharma.2023.05.005_bib0150","doi-asserted-by":"crossref","first-page":"116","DOI":"10.33590\/emj\/10313855","article-title":"Osteoarthritis and ageing","volume":"3","author":"Valdes","year":"2018","journal-title":"Eur Med J"},{"issue":"2","key":"10.1016\/j.pharma.2023.05.005_bib0155","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.pop.2018.02.009","article-title":"Approach to osteoarthritis management for the primary care provider","volume":"45","author":"Schmidt","year":"2018","journal-title":"Prim Care"},{"issue":"8","key":"10.1016\/j.pharma.2023.05.005_bib0160","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.joca.2018.04.018","article-title":"Defining the osteoarthritis patient: back to the future","volume":"26","author":"Dobson","year":"2018","journal-title":"Osteoarthritis Cartilage"},{"issue":"4","key":"10.1016\/j.pharma.2023.05.005_bib0165","first-page":"1","article-title":"Prescribing pattern and drug-drug interactions of analgesics prescribed for pain management in a Pakistani tertiary hospital","volume":"8","author":"Khan","year":"2016","journal-title":"J Appl Pharm"},{"issue":"2","key":"10.1016\/j.pharma.2023.05.005_bib0170","first-page":"80","article-title":"A retrospective study on potential drug interactions: a single centre experience","volume":"4","author":"Korucu","year":"2018","journal-title":"J Oncol"},{"year":"2007","series-title":"Principles of clinical pharmacology","author":"Robertson","key":"10.1016\/j.pharma.2023.05.005_bib0175"},{"issue":"762","key":"10.1016\/j.pharma.2023.05.005_bib0180","first-page":"1","article-title":"Potential drug-drug interactions in outpatient department of a tertiary care hospital in Pakistan: a cross-sectional study","volume":"18","author":"Ismail","year":"2018","journal-title":"BMC Health Serv Res"},{"year":"2019","series-title":"Sample size calculator","author":"Raosoft","key":"10.1016\/j.pharma.2023.05.005_bib0185"},{"key":"10.1016\/j.pharma.2023.05.005_bib0190","unstructured":"Chemical classification of drugs. National library of medicines. https:\/\/pubchem.ncbi.nlm.nih.gov\/. [Accessed: 22\/08\/2019]."},{"key":"10.1016\/j.pharma.2023.05.005_bib0195","unstructured":"World Health Organization. Anatomical, therapeutic, chemical classification. https:\/\/www.who.int\/tools\/atc-ddd-toolkit\/atc-classification. [Accessed: 20\/08\/2019]."},{"year":"2019","series-title":"Drug interaction checker","author":"Medscape","key":"10.1016\/j.pharma.2023.05.005_bib0200"},{"key":"10.1016\/j.pharma.2023.05.005_bib0205","unstructured":"IBM SPSS software. https:\/\/www.ibm.com\/analytics\/spss-statistics-software. [Accessed: 20\/08\/2019]."},{"issue":"3","key":"10.1016\/j.pharma.2023.05.005_bib0210","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.joca.2017.10.016","article-title":"Osteoarthritis biomarkers: year in review","volume":"26","author":"Watt","year":"2018","journal-title":"Osteoarthritis"},{"issue":"1","key":"10.1016\/j.pharma.2023.05.005_bib0215","first-page":"14","article-title":"Prevalence and predictors of polypharmacy among older primary care patients in Germany","volume":"24","author":"Theile","year":"2007","journal-title":"Fam Pract"},{"issue":"7","key":"10.1016\/j.pharma.2023.05.005_bib0220","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1136\/annrheumdis-2012-202745","article-title":"EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis","volume":"72","author":"Fernandes","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.pharma.2023.05.005_bib0225","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.joca.2010.01.013","article-title":"OARSI recommendations for the management of hip and knee osteoarthritis","volume":"18","author":"Zhang","year":"2010","journal-title":"Osteoarthritis"},{"issue":"5","key":"10.1016\/j.pharma.2023.05.005_bib0230","first-page":"14","article-title":"Pattern of drug prescribing in osteoarthritis patients attending orthopaedic outpatient department of a tertiary care hospital","volume":"6","author":"Shayam","year":"2016","journal-title":"Drug Deliv Ther"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450923000639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450923000639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T23:38:18Z","timestamp":1757720298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450923000639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0003450923000639"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2023.05.005","relation":{},"ISSN":["0003-4509"],"issn-type":[{"type":"print","value":"0003-4509"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential drug-drug interactions in patients presenting with osteoarthritis to community orthopaedic clinics of Abbottabad, Khyber Pakhtunkhwa: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2023.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}